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Introduction
Hysterosalpingography (HSG) is an x-ray diagnostic procedure for imaging of the uterus and fallopian tubes. Its applications consist of diagnosing causes of infertility in females, showing 
areas of scarring inside a fallopian tube or changing in the uterine cav-
ity, evaluating patients who have had several miscarriages, investigating 
patients prior to myomectomy, diagnosing cervico-uterus anomalies and 
locating intrauterine device that cannot be seen on a pelvic examination 
[1-3]. 
Original
ABSTRACT
Background: Hysterosalpingography (HSG) is an indispensable tool for diagnos-
ing infertility in females. The procedure exposes female reproductive organs to ion-
izing radiation as the genitals are irradiated during the process. Investigating patient 
absorbed dose during the procedures is essential for effective radiological protection 
of the patient. 
Objective: This study aims to investigate the radiation dose received by patient 
during HSG examination in the study environment in order to enhance optimization 
of procedures and the associated dose, thereby minimizing radiation risks. 
Material and Methods: The study was conducted in four tertiary healthcare 
institutions in Southwest Nigeria. Thermoluminescence dosimeter (TLD 100) was 
used to determine the Entrance Surface Dose (ESD) of 80 patients presented for HSG 
investigation. The corresponding effective dose, ovary, uterus and urinary bladder 
doses were evaluated using PCXMC software. 
Results: The means entrance surface dose (ESD) obtained from the four centers 
were 18.58±6.31 mGy, 15.18±2.27 mGy, 17.44±3.43 mGy and 34.24±11.98 mGy for 
SW1, SW2, SW3 and SW4 centers, respectively. The corresponding mean of effec-
tive doses were 1.54±0.63 mSv, 1.24±0.28 mSv, 1.41±0.30 mSv and 2.53±0.94 mSv 
for SW1, SW2, SW3 and SW4 centers, respectively.  The resulting mean doses to the 
ovary, urinary bladder and uterus were also presented. 
Conclusion: The results obtained in general are comparable with international 
standards. It was, however, recommended that study centers with high doses should 
conduct dose audit in order to enhance patient safety. 
Keywords
Hysterosalpingography,Thermoluminescence Dosimeters, Entrance Surface 
Dose, Effective Dose, Organ Doses
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The topmost indication for HSG investiga-
tions is infertility [4, 5]. Worldwide, 15% of 
reproductive-aged couples are affected by 
infertility. While in Sub-Sahara Africa more 
than 30% of women between the ages of 25 
and 49 suffer from secondary infertility [6, 7]. 
Secondary infertility has also been reported in 
Nigeria [8, 9]. Patients recommended for HSG 
are under pressure to alleviate the burden and 
stigma of infertility that they care less about 
the side effects of their examination. Even, 
large percent of these patients and some refer-
ring physicians are ignorant of risks associated 
with radiation dose. Ignorance of patients and 
physicians on the health implications of medi-
cal radiation examination has been reported 
[10, 11].
During HSG examinations, x-ray beam is 
focused on the female genital tract thus irradi-
ation of this organ is inevitable in the process. 
The uterus and ovaries are known to receive 
the highest dose as the pelvis is irritated. [5, 
12]. Organ involved must have the minimum 
exposure to radiation. Above all, several radio-
graphs are taken in order to visualize different 
views. The cumulative dose from these expo-
sures may result in the high dose to the region 
of interest, thereby leading to cancer induction 
or birth defect. According to literature, most 
patients recommended for HSG desire preg-
nancy [4, 13, 14]. As such, optimization of 
dose and image quality are essential. Though, 
hysterosalpingography has been considered as 
a low-risk examination yet, several factors can 
cause the patient to receive high dose radia-
tion. Variation in protocol from one healthcare 
institution to another one has been reported 
[14]. These variations result from limited un-
derstanding of procedures, state of available 
resources and multiple exposures among oth-
ers. Such lapses can lead to increasing radia-
tion dose to patients.
Hysterosalpingography is supposedly a 
fluoroscopic procedure and conducted us-
ing fluoroscopy facility. Modern fluoroscopic 
units have incorporated additional features 
minimizing radiation exposure [14]. However, 
some study centers employed conventional ra-
diography machine for this purpose. In centers, 
where fluoroscopic equipment is available, the 
machines are old and cannot deliver the de-
sired quality outcome. Technical errors and 
optimization of procedures will be unavoid-
able and faulted, respectively, thereby, leading 
to unnecessary irradiation of patients. The use 
of conventional x-ray machine and analogue 
fluoroscopy equipment for hysterosalpingog-
raphy have been reported to deliver high radia-
tion dose to the region of interest as compared 
to the digital fluoroscopy unit [4, 14]. If the 
exposure takes longer time, the dose will be 
received more by patients. According to [15], 
exposure time for normal hysterosalpingogra-
phy and abnormal procedure is about 54 and 
100 seconds on the average, respectively. The 
fluoroscopy procedure resulted in an entrance 
surface dose (ESD) of about 11 mGy. How-
ever, study by [14] using C-arm reported mean 
exposure time as 4.2 and 14.3 seconds for nor-
mal HSG and abnormal procedure, respective-
ly. They estimated the mean ESD as 2.6 ±9.8 
mGy and 6.9 ±10.7 mGy for normal procedure 
and abnormal procedure, respectively. This 
implies that the use of conventional radiogra-
phy machine for HSG is prolonged and deliv-
ers higher dose than fluoroscopy equipment. 
This correlation was observed in the study by 
Sulieman et al. who noted that hysterosalpin-
gography with fluoroscopic technique reduces 
patient dose by a factor of 3 [16]. 
Research by [12] recorded a dose of 4.5 mGy 
and 6.2 mGy for ovaries and uterus, respec-
tively, during assessment of hysterosalpingog-
raphy in Italy. A study by [17] reported radia-
tion dose of 2.7 mGy for female gonad with 
effective dose of 1.2 mSv. A similar  study 
conducted to evaluate patient absorbed dose 
during HSG in Nigerian hospital recorded a 
mean value of 5.87 ± 4.56 with a range of 0.02 
to 13.08 mGy [13]. Research carried out by 
[4] in order to investigate patient dosimetry 
in hysterosalpingography estimated the mean 
II
J Biomed Phys Eng
www.jbpe.ir HSG in southwest Nigeria
entrance surface dose to be 14.6 mGy. Similar 
investigation in Sudan reported mean entrance 
surface dose to be 20.9 mGy [5]. Complica-
tions arising from the irradiation of female 
pelvis have been reported in the literature. 
Some defects were noted, including ovarian 
failure, uterus impairment, premature labour, 
miscarriages among others [18, 19]. Though 
the dose due to HSG is relatively low, the ten-
dency for the incidence of cancer induction 
cannot be overruled. 
The goal of this study is to investigate effec-
tive dose to patient during hysterosalpingog-
raphy procedure in order to enhance the opti-
mization of dose and minimize the associated 
radiation risks. Also to generate baseline data 
that can be used to benchmark good practice 
for future research in the study region.
Material and Methods
This pilot research study was conducted in 
4 selected tertiary healthcare institutions in 
southwest Nigeria designated as SW1, SW2, 
SW3 and SW4, respectively. The quality con-
trol of the x-ray machines was conducted 
using MagicMax quality control kits (IBA 
Dosimetry, Germany). A total of 80 patients 
were examined for a period of six months 
with 20 patients from each center. Informed 
consent was obtained from each patient be-
fore the commencement of the examination. 
Institutional consent was obtained from each 
hospital used and also the Nigerian Institute 
of Medical Research (NIMR). Radiation dose 
measurements were made for patients during 
HSG procedure using thermoluminiscence 
dosimeters (TLD-100: LiF: Mg, Ti). The TLD 
chips were obtained from RadPro Interna-
tional GmbH, Germany. The chips were oven-
annealed using Carbolite oven made in Eng-
land. Irradiation of chips was conducted at the 
Secondary Standard Dosimetry Laboratory 
(SSDL) of the National Institute of Radiation 
Protection and Research (NIRPR), Ibadan. 
Calibration of TLD chips and reader were 
conducted and TLD chips were read using 
Harshaw Reader (Model 3500) at the Depart-
ment of Physics, Obafemi Awolowo univer-
sity Ile-Ife. Each of the TLD was enclosed in 
labelled black polythene pack. A total of three 
coded chips were used to measure the entrance 
surface dose (ESD) during each procedure in 
order to obtain the mean and enhance preci-
sion. The chips were attached to an elastic tape 
and placed in the center of x-rays field where 
the beam was intercepted by the irradiated part 
of the patient. These chips were made to re-
main fixed on the patient throughout the entire 
procedure.
Patient’s clinical information and exposure 
parameters were noted and recorded using 
self-structured form. PCXMC software (ver-
sion 20Rotation) was used to evaluate the ef-
fective and organ doses. Statistical analysis of 
data was carried out using SPSS (Version 23) 
and Microsoft excel.
Results
Specifications of machine used for investi-
gation are presented in Table 1. Analysis of 
radiation doses, exposure parameters and pa-
tients’ parameters in each study center are as 
shown in Table 2. The result obtained showed 
that infertility (58%) is the major cause for 
Machine Parameters
Names of diagnostic centers
SW1 SW2 SW3 SW4
Name of Machine Toshiba GE Allengers GE
Type of Machine Computed Conventional Computed Conventional
Year of Manufacture 2011 2007 2014 2010
Filtration (mmAl) 0.90 1.60 0.90 0.83
Table 1: Specification of machine used for hysterosalpingography in the study centers.
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 N Mean Std. Deviation Minimum Maximum
ESD
SW1 20 18.58 6.31 10.33 31.07
SW2 20 15.18 2.27 10.94 18.61
SW3 20 17.44 3.43 11.45 21.99
SW4 20 34.24 11.98 20.04 61.22
Total 80 21.36 10.28 10.33 61.22
kVp
SW1 20 92.10 5.71 84.00 100.00
SW2 20 74.70 3.40 70.00 78.00
SW3 20 91.65 6.82 82.00 105.00
SW4 20 87.25 3.80 80.00 90.00
Total 80 86.43 8.68 70.00 105.00
mAs
SW1 20 26.20 2.59 24.00 30.00
SW2 20 26.80 4.74 20.00 32.00
SW3 20 34.50 15.97 25.00 75.00
SW4 20 82.10 20.01 64.00 125.00
Total 80 42.40 26.60 20.00 125.00
FDD
SW1 20 100.75 5.91 90.00 110.00
SW2 20 103.50 4.89 100.00 115.00
SW3 20 100.75 5.91 90.00 110.00
SW4 20 96.00 13.73 70.00 110.00
Total 80 100.25 8.67 70.00 115.00
FSD
SW1 20 71.75 2.88 65.00 75.00
SW2 20 78.05 4.08 72.00 89.00
SW3 20 74.15 4.37 68.00 83.00
SW4 20 70.25 13.04 41.00 88.00
Total 80 73.55 7.76 41.00 89.00
BMI
SW1 20 26.58 3.19 21.48 34.77
SW2 20 23.64 2.38 19.92 28.13
SW3 20 25.59 2.89 19.14 30.08
SW4 20 26.31 2.62 21.88 31.25
Total 80 25.53 2.97 19.14 34.77
Age
SW1 20 35.90 4.81 27.00 49.00
SW2 20 36.00 3.32 30.00 41.00
SW3 20 34.35 3.13 28.00 40.00
SW4 20 33.70 3.28 29.00 39.00
Total 80 34.99 3.76 27.00 49.00
ESD = entrance surface dose, kVp = Kilovoltage peak, mAs = current time product, FDD = focus detec-
tor distance, FSD = focus skin distance, BMI = Body mass index
Table 2: Analysis of variance 
IV
J Biomed Phys Eng
www.jbpe.ir HSG in southwest Nigeria
HSG examinations in the study centers as 
depicted in Figure 1. Sample of 5 anatomi-
cal views of HSG in one of the study centers 
is as shown in Figure 2. The means entrance 
surface dose (ESD) obtained from the four 
centers were 18.58±6.31 mGy, 15.18±2.27 
mGy, 17.44±3.43 mGy and 34.24±11.98 mGy 
for SW1, SW2, SW3 and SW4 centers, re-
spectively. The corresponding mean effective 
doses were 1.54±0.63 mSv, 1.24±0.28 mSv, 
1.41±0.30 mSv and 2.53±0.94 mSv for SW1, 
SW2, SW3 and SW4 centers, respectively as 
shown in Figure 3. The doses of ovary, uterus 
and urinary bladder are 3.51 mGy, 4.35 mGy 
and 8.98 mGy for SW1, respectively, 2.81 
mGy, 3.49 mGy and 7.23 mGy for SW2, re-
spectively, 2.96 mGy, 3.87 mGy and 8.31 
mGy for SW3, respectively, and 5.54 mGy, 
6.95 mGy, and 14.68 mGy for SW4, respec-
tively, as shown in Figures 4. Correlation plots 
between the measured entrance surface dose 
(ESD) and exposure parameters are presented 
in Figure 5. Figure 6 compares the results ob-
tained in this study with similar studies in lit-
Figure 1: Indications for hysterosalpingography examinations.
Figure 2: Five anatomical views during hysterosalpingography in one of the study cente
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Figure 3: Chart showing the mean entrance 
surface dose and exposure parameters in 
the study centers.
Figure 4: Chart showing the mean effective 
dose (ED), ovarian dose (OD), uterus dose 
(UD) and urinary bladder dose (UBD) in the 
study centres.
Figure 5: Correlation plots between ESD and exposure parameters (a) centre SW1 (b) centre 
SW2 (c) centre SW3 (d) centre SW4.
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erature.
Discussion
Several studies have been conducted on hys-
terosalpingography (HSG) in different parts of 
the world [2, 3, 8]. To the best of our knowl-
edge, no study has been conducted on radia-
tion dose measurement during the procedures 
in Southwest, Nigeria. The work of Okeji et al. 
was conducted in Southeast Nigeria and so far 
the only one reported in literature with regards 
to radiation dose measurement [13]. The world 
over, few studies have been published regard-
ing the radiation doses received by patients 
during HSG. Similar observation has been 
noted by other authors [4, 20]. HSG examina-
tions are often conducted due to infertility [8, 
21]. Same one was observed in this study. The 
prevalence of infertility in Sub-Sahara Africa 
is widely reported [6, 7]. It is essential that ra-
diation dose absorbed by patients during the 
procedure is monitored in order to minimize 
the risks to irradiated reproductive organs.
Imaging modalities have been noted to de-
liver to patients in a wide range of doses [20, 
22-27]. Same trend has been observed in this 
study; there is a large variation in the entrance 
surface dose (ESD) within the same hospital 
and from one center to others (Table 2). The 
disparity between the minimum and maxi-
mum ESD in the study centers is in the ratio 
1:3.0, 1:1.7, 1:1.9 and 1:3.1 for SW1, SW2, 
Figure 6: Comparison of (a) entrance surface dose (ESD) and effective dose (E) (b) exposure 
parameters (c) organ dose with other authors 
 
0
5
10
15
20
25
30
R
ad
ia
tio
n 
D
os
e 
Authors 
ESD (mGy)
E (mSv)
(a) 
0
10
20
30
40
50
60
70
80
90
100
Pl
ec
as
 e
t a
l. 
20
10
O
ke
ji 
et
 a
l. 
20
11
G
ye
ky
e 
et
 a
l. 
20
12
A
lz
im
am
i e
t a
l. 
20
15
Y
ou
se
f e
t a
l. 
20
15
Th
is
 st
ud
y,
 2
01
8Ex
po
su
re
 P
ar
am
et
er
s 
Authors 
kVp
mAs
(b) 
0
1
2
3
4
5
6
7
O
rg
an
 D
os
es
 (m
G
y)
 
Authors 
Ovarian
Dose
Uterus
Dose
(c) 
  
VII
J Biomed Phys Eng
www.jbpe.irAchuka J. A. et al
SW3 and SW4, respectively. The large varia-
tions within the same hospital are traceable to 
inconsistency in the selection of exposure pa-
rameters, inadequate quality control measures, 
and lack of uniform protocol and multi-tasking 
of imaging system among others. Variation 
between hospitals can be linked to the usage 
of different equipment (Table 1) and lack of 
guidance level for references. 
However, the mean entrance surface dose 
(ESD) in this study is comparable except for 
center SW4. This implies dose harmonization 
is possible from one hospital to another one. 
The high dose recorded in center SW4 was 
due to the type of imaging system and inad-
equate quality control measures. The conven-
tional radiography machine used in the center 
is the capacitive type. The mechanism of the 
equipment sometimes warranted taking re-
peated exposure that consequently increased 
the ESD. Another paramount factor is the high 
tube current used. There was strong correla-
tion between the ESD and mAs as shown in 
Figure 5d. ESD is proportional to the tube cur-
rent and boosts as tube current increase [20, 
22]. 
The ESD lower values reported for center 
SW1 and SW3 is attributable to the use of 
computed radiography. Digital systems are 
known to deliver lower dose as compared to 
conventional radiography [4, 14]. In addition, 
the centers dedicated an x-ray machine specif-
ically for fluoroscopic procedures. Such deci-
sion enhances the efficiency of machine and 
consequently the machine output. Center SW2 
has the least range and the lowest mean ESD. 
Lower ESD values recorded is traceable to the 
correct use of exposure parameters. The cen-
ter uses lower kVp and mAs values while the 
FFD was higher as compared to other centers. 
This is indicative of adherence to ALARA (as 
low as reasonably achievable) principle and 
skillful personnel in the center. Furthermore, 
the participants in the center have had lower 
body mass index (BMI) in general. Since tube 
voltage is chosen according to patient BMI, 
invariably low BMI will culminate in low 
dose. The influence of exposure parameters on 
ESD is paramount as a little shift in every pa-
rameter has a significant impact on the patient 
absorbed dose (Figure 5). It is on this basis the 
radiation regulatory authorities demand opti-
mization of procedure.
Effective dose (ED) is a measure of radia-
tion risk. The mean effective dose in the cen-
ters ranged from 1.24 mSv in center SW2 to 
2.53 mSv in center SW4. Since effective dose 
is evaluated by ESD, its value will follow the 
same trend as ESD values in the study cen-
ters. Same trend follows for the evaluated or-
gan doses (ovary, uterus, urinary bladder) as 
shown in Figure 4. Center SW2 has the least 
doses given by 2.81 mGy, 3.49 mGy and 7.23 
mGy for ovary, uterus and urinary bladder 
doses, respectively. Centre SW4 has the high-
est values given by 5.54 mGy,6.95 mGy and 
14.68 mGy in the same order. In all the cen-
ters, urinary bladder doses were higher than 
ovary and uterus doses. Similar results have 
been noted by other authors [5, 28]. This is 
due to the position of the bladder with respect 
to the irradiated organ.
The range of ESD values reported in this 
study is comparable with many results report-
ed in literature (Figure 6a). Though the cumu-
lative mean ESD value (21.36 mGy) is higher 
than some previous studies, this can be attrib-
uted to the result from center SW4. Moreover, 
the tube voltage used in this study is some-
what higher than that used by other authors. 
The study of [20] recorded a higher dose with 
lower tube voltage to the present study. The 
type of TLD used by the authors might be re-
sponsible for this anomaly. For [12], the tube 
voltage was not reported, but the ESD value 
was higher than that from this study. The mean 
ESD value obtained by [5] is in close approxi-
mation with present study. This confirms the 
possibility of dose harmonization. Although it 
has been reported that doses from fluoroscopy 
procedures can vary as much as ten times for 
the same fluoroscopy time [29]. The method 
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employed in the determination of ESD by 
various authors, the choice of exposure pa-
rameters, the specificity of imaging equipment 
among others are some of the significant fac-
tors responsible for patient dose variability. 
Cumulative effective dose from this study is 
also comparable with previous studies (Figure 
6a). The contrast in some values is due to vari-
ous software and formulae used to estimate 
effective dose by various authors. United Na-
tions Scientific Committee on the Effects of 
Atomic Radiation [30] gave a value of 1.2 mSv 
for effective dose arising from hysterosalpin-
gography. This value is for single author. It is 
important that doses from several authors are 
harvested to enable the development of guid-
ance level, thereby minimizing patient dose. 
Similarly, the organ doses from this study are 
comparable with other studies (Figure 6c). 
The disparity noted is attributable to tools of 
estimation used by other authors. Above all, 
parameters influencing the ESD value report-
ed in this study are also contributing factors 
responsible for the variation in effective and 
organ doses. Previous authors did not report 
doses to the urinary bladder, except for [5, 28]. 
This explains why the value was not in Figure 
6c. Radiation doses during hysterosalpingog-
raphy cannot be overlooked irrespective of the 
dose value because cancer induction has no 
threshold. More so, reproductive organs aspir-
ing for fertility are being irradiated and these 
organs are highly sensitive to radiation. It is 
therefore essential that periodic dose audit be 
conducted for optimization.
Conclusion
The measurement of radiation dose during 
hysterosalpingography was investigated using 
thermoluminescence dosimeters. The dose in-
dices evaluated were relatively high but com-
parable to previous studies. Significant factors 
that influenced doses in the study centers con-
sist of the quality and usage of imaging equip-
ment, exposure parameters, the level of skill 
expertise and adherence to ALARA principle. 
Results of our study revealed the possibility 
of dose harmonization between hospitals with 
variant equipment and protocol. The authors 
recommend comprehensive clinical audit in 
centers with high doses.
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